{
    "code": "01022241",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01022241",
    "time": "2019-07-26 03:41:05",
    "許可證字號": "衛署藥製字第022241號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/25",
    "發證日期": "69\/09\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102224107",
    "中文品名": "舒肌痛注射液（奧菲那特林）",
    "英文品名": "TENSIONLEX INJECTION (ORPHENADRINE) &quot;PANHIOTIC&quot;",
    "適應症": "肌肉僵硬、疼痛、扭傷、局部肌肉損傷、椎間盤脫臼、腰背痛、纖維織炎、非關節性風濕炎、骨折、外科手術後焦慮、緊張",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "ORPHENADRINE CITRATE",
    "主製造廠": {
        "申請商名稱": "1405522200  臺灣汎生製藥廠股份有限公司",
        "申請商地址": "高雄市鳥松區坔埔里大同路5-1號及神農路330號",
        "主製造廠": "",
        "製造廠名稱": "1405522300  臺灣汎生製藥廠股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "60",
            "含量": "60.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "說明書-舒肌痛注射液-103-07-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022241&Seq=003&Type=9"
        },
        {
            "title": "舒肌痛注射液外盒-104-12-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022241&Seq=001&Type=8"
        }
    ]
}